β-LGND1
Overview[edit]
β-LGND1, also known as beta-ligand 1, is a protein that plays a significant role in various cellular processes, including signal transduction and gene expression regulation. It is a member of the ligand family of proteins, which are known for their ability to bind to specific receptors and influence cellular activity.
Structure[edit]
The β-LGND1 protein is characterized by its unique structural domains that facilitate its interaction with other proteins and receptors. It typically consists of several key domains:
- Ligand-binding domain (LBD): This domain is responsible for the specific binding of β-LGND1 to its target receptors. The LBD is highly conserved across different species, indicating its crucial role in the protein's function.
- Transactivation domain (TAD): This domain is involved in the activation of transcription factors, which are proteins that help turn specific genes on or off.
- Nuclear localization signal (NLS): This sequence of amino acids directs the protein to the cell nucleus, where it can influence gene expression.
Function[edit]
β-LGND1 is primarily involved in the regulation of gene expression. It acts as a coactivator for various transcription factors, enhancing their ability to promote the transcription of target genes. This function is critical in processes such as cell growth, differentiation, and response to external stimuli.
In addition to its role in gene expression, β-LGND1 is also involved in:
- Signal transduction: It participates in signaling pathways that transmit information from the cell surface to the nucleus, influencing cellular responses.
- Cell cycle regulation: By modulating the expression of genes involved in the cell cycle, β-LGND1 helps control cell proliferation.
Clinical Significance[edit]
Alterations in the expression or function of β-LGND1 have been implicated in various diseases, including cancer. Overexpression of β-LGND1 can lead to uncontrolled cell growth and tumor development, making it a potential target for cancer therapy.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which β-LGND1 influences cellular processes and its potential as a therapeutic target. Studies are also exploring its role in other diseases, such as metabolic disorders and neurodegenerative diseases.
Also see[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian